Post hoc analysis reveals dupilumab improves symptom burden in adults with prurigo nodularis, suggesting effective treatment options.
Patients treated with dupilumab showed greater improvement in DSB with respect to itch, skin pain, and sleep disturbance than those receiving placebo.
No takes yet. Share an insight, caveat, or question.
Kwatra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: